Cookies on this site

RDM researchers have outlined the potential benefits and limitations of new spatial transcriptomic technologies for mapping the bone marrow in patients with blood cancer.

Dr Rosalin Cooper, Emily Thomas and Professor Daniel Royston and colleagues are using spatial transcriptomic (ST) technologies to create a spatial map of the bone marrow in patients with blood cancer. Their paper, published in Leukemia, draws on their recent experience, providing an overview of these technologies, and outlining a framework of good practice for tissue-based quality control (QC) for ST analysis.

Dr Cooper, from RDM’s Nuffield Division of Clinical Laboratory Sciences (NDCLS) said: ‘Many blood cancers develop in the bone marrow. Our understanding of why people develop blood cancer is limited by our ability to quantify marrow-based features. This is also a major barrier to the development of better diagnostic pathways.

‘These novel ST technologies allow us to systematically quantify the marrow microenvironment, identifying spatial relationships between cells. This will allow us to create a ‘spatial map’ of the bone marrow in patients with blood cancer.’

Researcher Emily Thomas added: ‘These platforms have huge potential. However, we find that there are pitfalls related to tissue-based QC. The workflow we outline addresses these features and will be useful to other researchers in future.’

Professor Royston, from NDCLS, said: ‘We hope our work will underpin the development of both new pathobiological insights into the bone marrow microenvironment, and support the development of tools that will help the care team diagnose patients and plan the best treatment for patients with blood cancer.’

Similar stories

Type 1 diabetes research centre at University of Oxford marks its first year

Scientists and clinicians are making progress towards a better future for people affected by type 1 diabetes, by exploring how to delay the onset of the condition, develop new treatments, and improve everyday care.

European grant to investigate how tissue ageing influences cancer development

An international team of researchers, including Professor Alison Simmons, has been awarded a €13.97 million Synergy Grant from the European Research Council (ERC) to investigate how ageing in tissues influences the development of cancer.

Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation

Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.

£520,000 grant to test treatment for haemophilia-related ankle arthritis

Dr Nikki Curry from the Radcliffe Department of Medicine, and Steph Taylor from the Oxford Haemophilia & Thrombosis Centre, have been awarded a clinical trial grant from the National Institute of Health and Care Research for Patient Benefit (NIHR RfPB) funding stream to improve treatment for the ankle arthritis caused by haemophilia.

Researchers highlight need for better sleep support for NHS shift workers

A new study led by researchers at the University of Oxford’s Radcliffe Department of Medicine, has found that many NHS staff working shifts experience sleep difficulties, with researchers calling for more accessible, evidence-based support to help staff manage sleep.

Oxford spin-out raises $90 million to advance new treatments for blood cancers

Alethio Therapeutics, a University of Oxford spin-out co-founded by Professors Adam Mead and Beth Psaila, has secured $90 million (£67 million) in oversubscribed Series A financing to develop a new generation of therapies for myeloproliferative neoplasms (MPNs).

Similar stories

Type 1 diabetes research centre at University of Oxford marks its first year

Scientists and clinicians are making progress towards a better future for people affected by type 1 diabetes, by exploring how to delay the onset of the condition, develop new treatments, and improve everyday care.

European grant to investigate how tissue ageing influences cancer development

An international team of researchers, including Professor Alison Simmons, has been awarded a €13.97 million Synergy Grant from the European Research Council (ERC) to investigate how ageing in tissues influences the development of cancer.

Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation

Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.

£520,000 grant to test treatment for haemophilia-related ankle arthritis

Dr Nikki Curry from the Radcliffe Department of Medicine, and Steph Taylor from the Oxford Haemophilia & Thrombosis Centre, have been awarded a clinical trial grant from the National Institute of Health and Care Research for Patient Benefit (NIHR RfPB) funding stream to improve treatment for the ankle arthritis caused by haemophilia.

Researchers highlight need for better sleep support for NHS shift workers

A new study led by researchers at the University of Oxford’s Radcliffe Department of Medicine, has found that many NHS staff working shifts experience sleep difficulties, with researchers calling for more accessible, evidence-based support to help staff manage sleep.

Oxford spin-out raises $90 million to advance new treatments for blood cancers

Alethio Therapeutics, a University of Oxford spin-out co-founded by Professors Adam Mead and Beth Psaila, has secured $90 million (£67 million) in oversubscribed Series A financing to develop a new generation of therapies for myeloproliferative neoplasms (MPNs).